Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Viroscience department, Erasmus MC, Rotterdam, the Netherlands.
Euro Surveill. 2020 Feb;25(6). doi: 10.2807/1560-7917.ES.2020.25.6.2000082. Epub 2020 Feb 11.
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.
及时发现新型冠状病毒（2019-nCoV）感染病例对于阻断该病毒的传播至关重要。我们评估了 30 个欧盟/欧洲经济区（EU/EEA）国家的专门实验室进行 2019-nCoV 分子检测所需的专业知识和能力。截至 2020 年 1 月 29 日，24 个欧盟/EEA 国家的 38 个实验室已具备诊断检测手段。预计到 2 月中旬，所有欧盟/EEA 国家都将具备这一手段。引物/探针、阳性对照和人员的可用性是主要的实施障碍。
Zotero 插件
